
Skin problems related to antiphospholipid syndrome | HSS
2021年1月19日 · Livedo is the most common skin problem associated with APS. However, there are two types of livedo: livedo reticularis and livedo racemosa. Livedo reticularis (Picture 1) is a netlike or mottled pattern of purplish discoloration on the skin, which reflects the network of blood vessels within the skin.
Antiphospholipid Syndrome: Symptoms, Diagnosis & Treatment
2024年10月21日 · What are antiphospholipid syndrome symptoms? Some people with antiphospholipid syndrome notice mottled skin (livedo reticulitis) with a darkened, lace-like pattern. But most people with APS don’t experience any noticeable symptoms until they have a blood clot or experience a pregnancy complication. Symptoms of a blood clot can include: Chest ...
Livedo reticularis: A review of the literature - PMC
Livedo reticularis (LR) is a cutaneous physical sign characterized by transient or persistent, blotchy, reddish-blue to purple, net-like cyanotic pattern. LR is a benign disorder affecting mainly middle-aged females, whereas livedo racemosa (LRC) is pathologic, commonly associated with antiphospholipid antibody syndrome.
Cutaneous Manifestations of Antiphospholipid Antibody Syndrome
2008年2月1日 · Livedo reticularis is the most frequently associated cutaneous manifestation in patients who have APS, observed as the presenting sign in up to 40% of patients and seen in up to 70% of patients who have systemic lupus erythematosus (SLE) and APS [1].
Livedo racemosa is characterized livedo reticularis, netlike patterning from which of the skin similar it differs by its only on generalized the limbs, and but widespread, non-infiltrated, on the trunk and/or buttocks), its location.
Livedo reticularis is a marker for predicting multi-system
Livedo reticularis is a frequent cutaneous manifestation in patients with APS. Its high association with cardiac and CNS thrombosis may suggest that LR-APS patients compose a subset at higher risk for thrombosis, and thus may require a closer follow-up and a …
Antiphospholipid Syndrome and Potential New Treatments | HSS
2017年7月31日 · Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by production of antibodies – antiphospholipid antibodies (aPL) – that “attack” the person’s own body, resulting in blood clots and/or pregnancy complications. Antiphospholipid-antibody-positive patients also may develop other clinical problems. These may include:
Antiphospholipid syndrome (APS) - Symptoms - NHS
In antiphospholipid syndrome (APS), the immune system produces abnormal antibodies that make the blood "stickier" than normal. This means people with APS are more likely to develop …
Dermatologic manifestations of the antiphospholipid syndrome: …
The dermatologic manifestations of APS are frequently the presenting feature of the syndrome, and livedo reticularis is significantly associated with the arterial subset of APS.
Antiphospholipid syndrome - DermNet
Antiphospholipid syndrome is an acquired autoimmune disorder characterised by recurrent arterial or venous thrombosis and/or pregnancy losses, in the presence of persistently elevated levels of anticardiolipin antibodies and/or evidence of circulating lupus anticoagulant (these abnormalities are detected by blood tests).